1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4: Clinical outcome
Outcome 
Parenchymal hematoma type 1 and 2 7.5% (3/40)
Symptomatic hemorrhage 5.3% (2/38)
90-Day mRS available 85% (34/40)
 0 2.9% (1/34)
 1 17.1% (6/34)
 2 5.9% (2/34)
 3 5.9% (2/34)
 4 0% (0/34)
 5 11.8% (4/34)
 6 55.9% (19/34)

Outcome
Parenchymal hematoma type 1 and 2	7.5% (3/40)
Symptomatic hemorrhage	5.3% (2/38)
90-Day mRS available	85% (34/40)
0	2.9% (1/34)
1	17.1% (6/34)
2	5.9% (2/34)
3	5.9% (2/34)
4	0% (0/34)
5	11.8% (4/34)
6	55.9% (19/34)